ArticleIDCases2026
Severe acute respiratory distress syndrome associated with human metapneumovirus infection in a morbidly obese adult.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human metapneumovirus (hMPV) is a recognized cause of respiratory tract infections and can occasionally lead to severe pneumonia and acute respiratory distress syndrome (ARDS) in adults. However, reports describing the clinical course and management of hMPV-associated ARDS in adults remain limited. We report a case of severe ARDS caused by hMPV infection in a morbidly obese adult who achieved a favorable outcome with standard ARDS management. A 58-year-old man with morbid obesity (body mass index 36.6 kg/m²) was admitted to a previous hospital with fever and cough. Due to rapidly progressive hypoxemia, he was transferred to our hospital. On arrival, he exhibited severe hypoxemia (PaO₂/FiO₂ ratio of 90 mmHg) and was diagnosed with severe ARDS based on the global definition of ARDS, requiring invasive mechanical ventilation. Respiratory multiplex polymerase chain reaction testing identified hMPV on hospital day (HD) 2, and systemic corticosteroid therapy was discontinued because bacterial infection was considered unlikely. Standard ARDS management, including a low tidal volume strategy and prone positioning under neuromuscular blockade, resulted in rapid improvement in oxygenation. The patient was extubated on HD 5 and subsequently managed with high-flow nasal cannula oxygen therapy and noninvasive positive pressure ventilation. He was discharged on HD 11 without supplemental oxygen. This case highlights that hMPV infection can cause severe ARDS in morbidly obese adults and underscores the importance of early etiological diagnosis using respiratory multiplex PCR testing, as well as appropriate implementation of standard ARDS management, even in severe ARDS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.